Envision has achieved sixth position in the annual ranking of the UK’s Top 50 fastest-growing privately owned pharma businesses.
This marks the second successive year Envision has reached financial services firm Alantra’s Pharma Fast 50 list. Based on revenue growth, it recognizes the key British companies that are driving the healthcare sector forward.
Envision CEO David Thompson said, “We are very proud to be named once again in the Pharma Fast 50 list. To move from 19th place in 2019 to sixth in the rankings this year, speaks to all the hard work and dedication our superb team has put in as we continue to expand our technology-enabled scientific services for clients.”
Alantra Director and report author Tom Cowap comments in the publication, “These are dynamic and innovative businesses that continue to deliver remarkable growth and we are proud to highlight their success.”
Aside from additional recent industry awards that have been based on client campaigns and innovation within the sector, Envision as a business has previously enjoyed year-on-year accolades:
2019 – Positioned 19th in Alantra Pharma Fast 50, fastest-growing privately owned pharma business
2018 – Awarded at Super Sussex Growth event that highlighted top-performing, job-generating businesses
2017 – Named Best in Business for sustained sales growth as a mid-market company among the Top 20 fastest-growing businesses
To view the 2020 Pharma Fast 50 report, click here.